Paper. Klaiber A, Vizeli P, Varghese N et al.. Journal of Psychopharmacology, 19 Nov 2026.
Tags: Psilocybin, LSD, Mescaline.
A 5-HT2A antagonist abolished mescaline's empathy effect in a 16-person crossover study.
Healthy volunteers received placebo, four mescaline doses from 100 to 800 mg, and 800 mg plus 40 mg ketanserin, double-blind and in random order. Emotional empathy rose on mescaline and the receptor blocker took it away, alongside measured plasma oxytocin.
How much weight it carries: Well-controlled crossover with an antagonist arm, but 16 healthy volunteers and an acute laboratory measure with no clinical endpoint. (Humans, Double-blind, Placebo-controlled, Controlled, Small sample, Mechanism, n = 16)